470 related articles for article (PubMed ID: 29022222)
1. T Cell Receptor Profiling in Type 1 Diabetes.
Jacobsen LM; Posgai A; Seay HR; Haller MJ; Brusko TM
Curr Diab Rep; 2017 Oct; 17(11):118. PubMed ID: 29022222
[TBL] [Abstract][Full Text] [Related]
2. Using the T Cell Receptor as a Biomarker in Type 1 Diabetes.
Nakayama M; Michels AW
Front Immunol; 2021; 12():777788. PubMed ID: 34868047
[TBL] [Abstract][Full Text] [Related]
3. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.
Seay HR; Yusko E; Rothweiler SJ; Zhang L; Posgai AL; Campbell-Thompson M; Vignali M; Emerson RO; Kaddis JS; Ko D; Nakayama M; Smith MJ; Cambier JC; Pugliese A; Atkinson MA; Robins HS; Brusko TM
JCI Insight; 2016 Dec; 1(20):e88242. PubMed ID: 27942583
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T cells in type 1 diabetes.
Pugliese A
J Clin Invest; 2017 Aug; 127(8):2881-2891. PubMed ID: 28762987
[TBL] [Abstract][Full Text] [Related]
5. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
Wagner DH
Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
[TBL] [Abstract][Full Text] [Related]
6. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Babon JA; DeNicola ME; Blodgett DM; Crèvecoeur I; Buttrick TS; Maehr R; Bottino R; Naji A; Kaddis J; Elyaman W; James EA; Haliyur R; Brissova M; Overbergh L; Mathieu C; Delong T; Haskins K; Pugliese A; Campbell-Thompson M; Mathews C; Atkinson MA; Powers AC; Harlan DM; Kent SC
Nat Med; 2016 Dec; 22(12):1482-1487. PubMed ID: 27798614
[TBL] [Abstract][Full Text] [Related]
7. Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes.
Nakayama M; Michels AW
Front Immunol; 2019; 10():365. PubMed ID: 30906293
[TBL] [Abstract][Full Text] [Related]
8. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the Pathogenesis of Human Type 1 Diabetes (T1D) by Interrogating T Cells from the "Scene of the Crime".
Kent SC; Mannering SI; Michels AW; Babon JAB
Curr Diab Rep; 2017 Sep; 17(10):95. PubMed ID: 28864875
[TBL] [Abstract][Full Text] [Related]
10. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
11. The short review on the studies of T cells receptors relate to type 1 diabetes.
Zhou J; Kong C; Chen X
Diabetes Metab Syndr; 2014; 8(4):252-4. PubMed ID: 25311819
[TBL] [Abstract][Full Text] [Related]
12. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
13. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
14. Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8
Peters LD; Yeh WI; Arnoletti JM; Brown ME; Posgai AL; Mathews CE; Brusko TM
Front Immunol; 2023; 14():1142648. PubMed ID: 37325626
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
17. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.
Serreze DV; Johnson EA; Chapman HD; Graser RT; Marron MP; DiLorenzo TP; Silveira P; Yoshimura Y; Nathenson SG; Joyce S
Diabetes; 2001 Sep; 50(9):1992-2000. PubMed ID: 11522664
[TBL] [Abstract][Full Text] [Related]
18. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
19. Changes in autoreactive T cell avidity during type 1 diabetes development.
Standifer NE; Burwell EA; Gersuk VH; Greenbaum CJ; Nepom GT
Clin Immunol; 2009 Sep; 132(3):312-20. PubMed ID: 19482555
[TBL] [Abstract][Full Text] [Related]
20. Circulating β cell-specific CD8
Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M
Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
